The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Units per Product
TIP 63: Medications for Opioid Use Disorder - Executive Summary
File Type: PDF
File Size: 1.1 MB